The IAEA has recently launched SAFRON for Radionuclide Therapy, an incident learning system to help medical facilities improve safety of patients and staff. The objective of this new learning system ...

After the Fukushima nuclear power plant accident, managing environmental radionuclide contamination efficiently has become incredibly important. In light of this, a team of scientists have provided ...

In terms of patient selection, workgroup members agreed that PSMA PET should be performed within three months of treatment or since progression on the last therapy to ensure that the current disease ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. Nuclear medicine plays a very important role in the ...

Prostate cancer is the most common cancer in men and at later stages of the disease many patients develop painful bone metastases. One promising modality for management of skeletal metastases is ...

Radionuclide therapy is an increasingly important modality in the treatment of various malignancies, utilising radiopharmaceuticals to deliver targeted cytotoxic radiation to diseased tissues. Central ...

Transaxial slices of baseline positron emission tomography (PET) and fused PET/magnetic resonance imaging (MRI; left) demonstrate a somatostatin receptor-expressing meningioma in the left cavernous ...

If you can get rid of circulating tumor cells and tumor cell clusters that detach from a tumor, spreading the disease in the body, cancer is less likely to return. This is the hope behind a ...

Exposure to radionuclides disseminated by a radiological dispersion device or deposited as fallout after a nuclear power plant accident or detonation of an improvised nuclear device could result in ...

γ-emitting isotopes are selected for diagnosis because the radiation they produce can be detected by specific instruments such as positron emission tomography (PET) or single-photon emission computed ...

Reston, VA (September 28, 2021)—A promising radionuclide treatment may offer new therapeutic options for breast cancer patients, according to research published in The Journal of Nuclear Medicine. The ...